Fibrin complement receptor 3 signaling (WP4136)

Homo sapiens

The blood protein fibrinogen, a key component of the coagulation cascade, has been identified as an early molecular factor triggering inflammation in the brain and periphery (see bibliography). Upon fibrinogen extravasation across leaky vessels (i.e., break down of the blood-brain barrier), fibrinogen is converted by thrombin to insoluble fibrin. Based on published studies, this signaling pathway highlights fibrin as a CD11b/CD18 (complement receptor; CR3) integrin receptor ligand that regulates innate immunity. Fibrin activates central nervous system (CNS) resident microglia and peripheral (bone marrow-derived) macrophages via CR3, leading to intracellular kinase signaling activation including PI3K, AKT1, and RhoA activity that regulates phagocytosis; and NF-κB translocation to the nucleus that transcriptionally regulates proinflammatory cytokines and chemokines that recruit T-cells and macrophages. Canonical LPS-TLR4 activation of innate immune cells and potential mechanisms of CD11b transactivation are shown. Proteins on this pathway have targeted assays available via the [https://assays.cancer.gov/available_assays?wp_id=WP4136 CPTAC Assay Portal]

Authors

Kristina Hanspers , Andrew Mendiola , Katerina Akassoglou , Egon Willighagen , Alex Pico , Eric Weitz , and Martina Summer-Kutmon

Activity

last edited

Discuss this pathway

Check for ongoing discussions or start your own.

Cited In

Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.

Organisms

Homo sapiens

Communities

Annotations

Pathway Ontology

coagulation cascade pathway inflammatory response pathway classical complement pathway inflammatory response pathway classical complement pathway coagulation cascade pathway

Cell Type Ontology

microglial cell microglial cell macrophage

Participants

Label Type Compact URI Comment
LPS Metabolite chebi:16412
Fibrin Metabolite chebi:5054
AKT1 GeneProduct ensembl:ENSG00000142208
IL6 GeneProduct ensembl:ENSG00000136244
IKBKB GeneProduct ensembl:ENSG00000104365
PI3K GeneProduct ncbigene:5290
Plasminogen GeneProduct ensembl:ENSG00000122194
SYK GeneProduct ensembl:ENSG00000165025
TLR3 GeneProduct ensembl:ENSG00000164342
CBL-B GeneProduct ensembl:ENSG00000114423
MYD88 GeneProduct ensembl:ENSG00000172936
IFNB1 GeneProduct ensembl:ENSG00000171855
RHOA GeneProduct ensembl:ENSG00000067560
IRAK1 GeneProduct ensembl:ENSG00000184216
tPA GeneProduct ensembl:ENSG00000104368
CXCL10 GeneProduct ensembl:ENSG00000169245
RAPL GeneProduct ensembl:ENSG00000266094
NFKB1 GeneProduct ensembl:ENSG00000109320
TIRAP GeneProduct ensembl:ENSG00000150455
TRAF6 GeneProduct ensembl:ENSG00000175104
TRIF GeneProduct ensembl:ENSG00000127666
CD14 GeneProduct ensembl:ENSG00000170458
DAP12 GeneProduct ensembl:ENSG00000011600
CXCL3 GeneProduct ensembl:ENSG00000163734
Plasmin GeneProduct ensembl:ENSG00000122194
IRAK4 GeneProduct ensembl:ENSG00000198001
MD2 GeneProduct ensembl:ENSG00000154589
LBP GeneProduct ensembl:ENSG00000129988
TLR4 GeneProduct ensembl:ENSG00000136869
SRC GeneProduct ensembl:ENSG00000197122
TRAF GeneProduct ensembl:ENSG00000243414
IRF3 GeneProduct ensembl:ENSG00000126456
CD11b GeneProduct ensembl:ENSG00000169896
CD18 GeneProduct ensembl:ENSG00000160255
TNF GeneProduct ensembl:ENSG00000232810
CCL2 GeneProduct ensembl:ENSG00000108691
CHUK GeneProduct ensembl:ENSG00000213341
IKBKG GeneProduct ensembl:ENSG00000269335
FGA GeneProduct ensembl:ENSG00000171560
IRAK2 GeneProduct ensembl:ENSG00000134070
IL12B GeneProduct ensembl:ENSG00000113302
NOS2 GeneProduct ensembl:ENSG00000007171
FGB GeneProduct ensembl:ENSG00000171564
FGG GeneProduct ensembl:ENSG00000171557
REL GeneProduct ensembl:ENSG00000162924
RELA GeneProduct ensembl:ENSG00000173039

References

  1. Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Caron E, Hall A. Science. 1998 Nov 27;282(5394):1717–21. PubMed Europe PMC Scholia
  2. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, et al. Science. 1998 Dec 11;282(5396):2085–8. PubMed Europe PMC Scholia
  3. Roles of PI3Ks in leukocyte chemotaxis and phagocytosis. Stephens L, Ellson C, Hawkins P. Curr Opin Cell Biol. 2002 Apr;14(2):203–13. PubMed Europe PMC Scholia
  4. Sequence gamma 377-395(P2), but not gamma 190-202(P1), is the binding site for the alpha MI-domain of integrin alpha M beta 2 in the gamma C-domain of fibrinogen. Ugarova TP, Lishko VK, Podolnikova NP, Okumura N, Merkulov SM, Yakubenko VP, et al. Biochemistry. 2003 Aug 12;42(31):9365–73. PubMed Europe PMC Scholia
  5. Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. Flick MJ, Du X, Witte DP, Jirousková M, Soloviev DA, Busuttil SJ, et al. J Clin Invest. 2004 Jun;113(11):1596–606. PubMed Europe PMC Scholia
  6. The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease. Adams RA, Bauer J, Flick MJ, Sikorski SL, Nuriel T, Lassmann H, et al. J Exp Med. 2007 Mar 19;204(3):571–82. PubMed Europe PMC Scholia
  7. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Park BS, Song DH, Kim HM, Choi BS, Lee H, Lee JO. Nature. 2009 Apr 30;458(7242):1191–5. PubMed Europe PMC Scholia
  8. Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b. Han C, Jin J, Xu S, Liu H, Li N, Cao X. Nat Immunol. 2010 Aug;11(8):734–42. PubMed Europe PMC Scholia
  9. Integrins limit the Toll. Means TK, Luster AD. Nat Immunol. 2010 Aug;11(8):691–3. PubMed Europe PMC Scholia
  10. Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation. Ryu JK, Petersen MA, Murray SG, Baeten KM, Meyer-Franke A, Chan JP, et al. Nat Commun. 2015 Sep 10;6:8164. PubMed Europe PMC Scholia